Literature DB >> 583234

[Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers (author's transl)].

G Blaschke, H P Kraft, K Fickentscher, F Köhler.   

Abstract

Racemic thalidomide is chromatographically separated on optically active polyamide giving both enantiomers. After i.p. administration only the S-(-)-enantiomer is teratogenic on SWS mice and Natal rats.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583234

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  28 in total

1.  Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.

Authors:  Masatomo Miura; Hitoshi Tada; Norio Yasui-Furukori; Tsukasa Uno; Kazunobu Sugawara; Tomonori Tateishi; Toshio Suzuki
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

Review 2.  Enantiomeric resolution of drug compounds by liquid chromatography.

Authors:  H T Karnes; M A Sarkar
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

Review 3.  Drug chirality and its clinical significance.

Authors:  A J Hutt; S C Tan
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Embryotoxic effects of thalidomide derivatives on the non-human primate Callithrix jacchus; 3. Teratogenic potency of the EM 12 enantiomers.

Authors:  W Heger; S Klug; H J Schmahl; H Nau; H J Merker; D Neubert
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 5.  Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancer.

Authors:  Tristan M Sissung; Silja Thordardottir; Erin R Gardner; William D Figg
Journal:  Anticancer Agents Med Chem       Date:  2009-12       Impact factor: 2.505

6.  Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4.

Authors:  Aneta Doricakova; Dirk Theile; Johanna Weiss; Radim Vrzal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-27       Impact factor: 3.000

Review 7.  Thalidomide and its derivatives: emerging from the wilderness.

Authors:  J N Gordon; P M Goggin
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

8.  Pharmacokinetics of (+)-rolipram and (-)-rolipram in healthy volunteers.

Authors:  W Krause; G Kühne; N Sauerbrey
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  The enantiomers of the teratogenic thalidomide analogue EM 12: 1. Chiral inversion and plasma pharmacokinetics in the marmoset monkey.

Authors:  H J Schmahl; H Nau; D Neubert
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

10.  Synthetic Studies of 3-(3-Fluorooxindol-3-yl)-l-alanine.

Authors:  Tomoya Fujiwara; Bin Yin; Meixiang Jin; Kenneth L Kirk; Yoshio Takeuchi
Journal:  J Fluor Chem       Date:  2008       Impact factor: 2.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.